跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 62 条关于
“BAFFR”
全部
62
临床试验
32
药物
21
机构
0
资讯
9
10个月前
PeproMene Bio's BAFFR-CAR T Therapy Shows Promising Results in Relapsed B-Cell Cancers
2年前
PeproMene Bio's BAFFR-CAR T Cell Therapy Shows Promise in Relapsed B-ALL Trial
去年
City of Hope Advances Novel AML Therapies and Unveils Breakthrough Research at ASH 2025
11个月前
Jade Biosciences Unveils JADE201, Half-Life Extended Anti-BAFF Receptor Antibody for Autoimmune Diseases
去年
Novel BAFF-R CAR-T Therapy Achieves Complete Response in Heavily Pretreated Follicular Lymphoma Patient
去年
PeproMene Bio Secures $11 Million Investment to Advance BAFF-R CAR T-Cell Therapy for Follicular Lymphoma
9天前
Lancet Publishes Phase 1 Data for PeproMene's BAFF-R CAR T: 80% Complete Response, Grade 1-Only Toxicity
10天前
PeproMene Bio's BAFF-R CAR T-Cell Therapy Shows 80% Complete Response Rate in Relapsed/Refractory B-Cell Lymphomas
3个月前
PeproMene Bio's BAFF-R CAR-T Therapy Shows 78% Complete Response Rate in B-Cell Lymphoma Patients After CD19 CAR-T Failure